(Q33998417)

30 July 2017

1 reference

title

Iboga interactions with psychomotor stimulants: panacea in the paradox? (English)

1 reference

30 July 2017

Szumlinski KK

1

1 reference

30 July 2017

Maisonneuve IM

series ordinal

2

1 reference

30 July 2017

Glick SD

series ordinal

3

1 reference

30 July 2017

publication date

1 January 2001

1 reference

30 July 2017

1 reference

30 July 2017

volume

39

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

75-86

1 reference

The Antagonism of Amphetamine-Induced Symptomatology by a Neuroleptic

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Dopamine functions in appetitive and defensive behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Psychostimulant sensitization: differential changes in accumbal shell and core dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

1 reference

7 January 2021

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Predictive validity of the extinction/reinstatement model of drug craving.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Changes in amphetamine sensitivity following frontal cortical damage in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Mechanisms of Antiaddictive Actions of Ibogainea.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

(±)-18-Methoxycoronaridine: A Novel Iboga Alkaloid Congener Having Potential Anti-Addictive Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Effects and aftereffects of ibogaine on morphine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Neurobiological vulnerability to low-dose amphetamine psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Evidence for a multi-compartmental histochemical organization of the nucleus accumbens in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

A role for sensitization in craving and relapse in cocaine addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Neural systems for behavioral activation and reward

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Research issues related to development of medications for treatment of cocaine addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Drug dependence: stress and dysregulation of brain reward pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Interaction of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Time-dependent interactions between iboga agents and cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Animal models of drug craving

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Sensitivity to subjective effects of cocaine in drug abusers: relationship to cerebral ventricle size

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Behavioral characterization of d- and l-amphetamine: neurochemical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Ibogaine antagonizes cocaine-induced locomotor stimulation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Ibogaine reduces preference for cocaine consumption in C57BL/6By mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

A preliminary investigation of ibogaine: case reports and recommendations for further study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Tolerance and sensitization to the behavioral effects of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Influence of novel and habituated testing conditions on cocaine sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

Amphetamine response in rat after dopamine neurone destruction.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900158-6

7 January 2021

10.1016/S0041-0101(00)00158-6

Identifiers

DOI

1 reference

30 July 2017

1 reference